395 filings
Page 17 of 20
S-3/A
u4rmym8 eoeykohh5h
13 Oct 11
Shelf registration (amended)
12:00am
UPLOAD
ykd quk1fh5
11 Oct 11
Letter from SEC
12:00am
8-K
g44qum 64f22y
6 Oct 11
Other Events
12:00am
8-K/A
uvgw76
5 Oct 11
Financial Statements and Exhibits
12:00am
S-3
164t42dcqve9
30 Sep 11
Shelf registration
12:00am
8-K
n7ybod5l
13 Sep 11
Ampio Pharmaceuticals’ Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane in South Korea
12:00am
8-K
a9rndhj0ftt1vequq
22 Aug 11
Ampio Pharmaceuticals Expands Business Development Capabilities with the hiring of Deborah Knobelman, Ph.D. as Chief Business Officer
12:00am
8-K
eqayk42nqc f0rvc6tp
7 Jul 11
Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
12:00am
8-K
660gneac 06jd
1 Jul 11
Regulation FD Disclosure
12:00am
S-8
rnchg4t3fh
27 Jun 11
Registration of securities for employees
12:00am
8-K
jdmxt kxojt
21 Jun 11
Regulation FD Disclosure
12:00am
8-K
6qc3s9wgsrvmmx vf0
8 Jun 11
Ampio Pharmaceuticals, Inc. Appoints New Independent Director
12:00am
424B3
zqktd31is2pi4lv
8 Jun 11
Prospectus supplement
12:00am
EFFECT
0wng wde0h
7 Jun 11
Notice of effectiveness
12:00am
8-K
pv5hvocaxnuf26d32fd
20 May 11
Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market
12:00am
8-A12B
8gkkngi4
17 May 11
Registration of securities on exchange
12:00am